Review of the Early Access to Medicines Scheme (EAMS)

The Early Access to Medicines Scheme (EAMS) aims to give patients with life threatening or seriously debilitating conditions access to medicines that do not yet have a marketing authorisation, when there is a clear unmet medical need. The scheme demonstrates a commitment from the UK to pharmaceutical innovation, providing a platform for drugs to be brought to patients at a much faster rate than ever before. We are looking for organisations that will work closely with the team to inform their wider work in developin...